Methods and compositions for the treatment and diagnosis of cellular proliferative disorders using 32222
AssigneeMillennium Pharmaceuticals, Inc.
InventorJohn Joseph Hunter
Life of this patent
Estimating the term…
Abstract
The present invention relates to methods and compositions for the treatment and diagnosis of cellular proliferative disorders, including, but not limited to, lung, breast, ovary, and colon tumors. The invention further provides methods for identifying a compound capable of treating a cellular proliferative disorder or modulating tumorigenesis. The invention also provides a method for modulating tumorigenesis, e.g., modulating tumorigenesis in a subject. In addition, the invention provides a method for treating a subject having a cellular proliferative disorder characterized by aberrant 32222 polypeptide activity or aberrant 32222 nucleic acid expression.
Claims13
A method for identifying a compound capable of treating a cell proliferation disorder, comprising assaying the ability of the compound to modulate 32222 nucleic acid expression or 32222 polypeptide activity, thereby identifying a compound capable of treating a cell proliferation disorder.
A method for identifying a compound capable of modulating cellular proliferation comprising:
- a) contacting a cell which expresses 32222 with a test compound;
- and
- b) assaying the ability of the test compound to modulate the expression of a 32222 nucleic acid or the activity of a 32222 polypeptide, thereby identifying a compound capable of modulating cellular proliferation.
A method for modulating cellular proliferation in a cell comprising contacting a cell with a 32222 modulator, thereby modulating cellular proliferation in the cell.
A method for treating a subject having a cell proliferation disorder characterized by aberrant 32222 polypeptide activity or aberrant 32222 nucleic acid expression comprising administering to the subject a 32222 modulator, thereby treating said subject having a cell proliferation disorder.
Dependencies are inferred from the claim text.